Literature DB >> 2857181

A 10-year assessment of controlled trials of inpatient and outpatient treatment and of plaster-of-Paris jackets for tuberculosis of the spine in children on standard chemotherapy. Studies in Masan and Pusan, Korea. Ninth report of the Medical Research Council Working Party on Tuberculosis of the Spine.

.   

Abstract

Two hundred and eighty-three patients with tuberculosis of the thoracic and/or lumbar spine have been followed for 10 years from the start of treatment. All patients received PAS plus isoniazid daily for 18 months, either with streptomycin for the first three months (SPH) or no streptomycin (PH), by random allocation. There was also a second random allocation for all patients: in Masan to inpatient rest in bed (IP) for six months followed by outpatient treatment or to ambulatory outpatient treatment from the start (OP), and in Pusan to outpatient treatment with a plaster-of-Paris jacket (J) for nine months or to ambulatory treatment without any support (No J). A favourable status was achieved on their allocated regimen by 88% of patients at 10 years. Some of the remaining patients also attained a favourable status after additional chemotherapy and/or operation, and if these are included the proportion achieving such a status increases to 96%. There were five patients whose deaths were attributed to their spinal disease. A sinus or clinically evident abscess was present on at least one occasion in the 10-year period in 42% of the patients. Residual sinuses persisted at 10 years in two patients, at death at seven years in a third and at default in the seventh year in a fourth. Thirty-five patients had paraparesis at some time during the 10-year period, including two who died with paraplegia before five years. Complete resolution occurred in 26 patients (in six after additional chemotherapy and/or surgery). At 10 years two patients had severe paraplegia and one a moderate paraparesis.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2857181

Source DB:  PubMed          Journal:  J Bone Joint Surg Br        ISSN: 0301-620X


  18 in total

1.  Operative treatment of spondylodiscitis--what is the most effective approach?

Authors:  C Hopf; A Meurer; P Eysel; J D Rompe
Journal:  Neurosurg Rev       Date:  1998       Impact factor: 3.042

2.  Primary stable anterior instrumentation or dorsoventral spondylodesis in spondylodiscitis? Results of a comparative study.

Authors:  P Eysel; C Hopf; I Vogel; J D Rompe
Journal:  Eur Spine J       Date:  1997       Impact factor: 3.134

3.  Atypical tuberculous spondylitis.

Authors:  M Sankaran-Kutty
Journal:  Int Orthop       Date:  1992       Impact factor: 3.075

Review 4.  Tuberculosis of spine: neurological deficit.

Authors:  Anil K Jain; Jaswant Kumar
Journal:  Eur Spine J       Date:  2012-05-08       Impact factor: 3.134

Review 5.  Osteomyelitis. Common causes and treatment recommendations.

Authors:  D R Dirschl; L C Almekinders
Journal:  Drugs       Date:  1993-01       Impact factor: 9.546

6.  Posterior approach in thoracolumbar tuberculosis: a clinical and radiological review of 67 operated cases.

Authors:  Saurabh Rawall; Kapil Mohan; Abhay Nene
Journal:  Musculoskelet Surg       Date:  2012-12-15

7.  [Specific spondylitis].

Authors:  V Bullmann; U R Liljenqvist; M Koriller; T Lange
Journal:  Orthopade       Date:  2012-09       Impact factor: 1.087

8.  Conservative treatment of tuberculosis of the thoracic and lumbar spine in adults and children.

Authors:  M S Moon; I Kim; Y K Woo; Y O Park
Journal:  Int Orthop       Date:  1987       Impact factor: 3.075

9.  Surgery for spinal tuberculosis: a multi-center experience of 582 cases.

Authors:  Md Shah Alam; Kevin Phan; Rezaul Karim; Sharif Ahmed Jonayed; Hasan Khalid Md Munir; Shubhendu Chakraborty; Tashfique Alam
Journal:  J Spine Surg       Date:  2015-12

Review 10.  Current and potential treatment of tuberculosis.

Authors:  S Houston; A Fanning
Journal:  Drugs       Date:  1994-11       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.